QT/QTc Intervals
Showing 1 - 25 of 4,057
Healthy Volunteers Trial in Miami (CTP-543, Moxifloxacin, Placebo)
Completed
- Healthy Volunteers
- CTP-543
- +2 more
-
Miami, FloridaClinical Pharmacology of Miami, LLC
Feb 16, 2022
Healthy Subjects Trial in Shanghai (TPN171H 10 mg Group, TPN171H 30 mg Group, TPN171H 40 mg Group)
Recruiting
- Healthy Subjects
- TPN171H 10 mg Group
- +3 more
-
Shanghai, Shanghai, ChinaHuashan Hospital affiliated to Fudan University
Feb 19, 2023
QT Intervals Changes, QTc Intervals Changes Trial in Leeds (Omecamtiv Mecarbil (OM), Placebo, Moxifloxacin)
Completed
- QT Intervals Changes
- QTc Intervals Changes
- Omecamtiv Mecarbil (OM)
- +2 more
-
Leeds, United KingdomResearch Site
Nov 2, 2021
QTc Intervals in Former Preterm/Extreme Low Birth Weight
Enrolling by invitation
- Qt Interval
- Preterm Birth
- ECG (diagnostic)
-
Leuven, Belgium
- +1 more
Jul 7, 2022
QT/QTc Trial in Austin (Ecopipam Hydrochloride, Moxifloxacin, Placebo)
Recruiting
- QT/QTc
- Ecopipam Hydrochloride
- +2 more
-
Austin, TexasPPD Austin Phase 1 Clinical Research Unit
Apr 21, 2023
Healthy Volunteers Trial in Tempe (Epetraborole and matching , Epetraborole, Placebo)
Active, not recruiting
- Healthy Volunteers
- Epetraborole and matching placebo
- +3 more
-
Tempe, Arizona423001
Aug 16, 2023
Healthy Trial in Merksem (Aticaprant Supratherapeutic Dose, Aticaprant Therapeutic Dose, Placebo)
Completed
- Healthy
- Aticaprant Supratherapeutic Dose
- +3 more
-
Merksem, BelgiumClinical Pharmacology Unit
Nov 9, 2022
Postpartum Hemorrhage Trial in Tempe (Carbetocin, Placebo, Placebo and Moxifloxacin)
Recruiting
- Postpartum Hemorrhage
- Carbetocin
- +2 more
-
Tempe, ArizonaFerring Investigational Site
Jun 20, 2023
Healthy Subjects Trial in Toshima-ku (TS-142, Moxifloxacin, Placebo)
Completed
- Healthy Subjects
- TS-142
- +2 more
-
Toshima-ku, JapanTaisho Pharmaceutical Co., Ltd selected site
Oct 5, 2022
TQT Study Trial in Tempe (Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) + Placebo, Moxifloxacin 400mg, Placebo for Tebipenem
Completed
- TQT Study
- Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) + Placebo
- +3 more
-
Tempe, ArizonaCelerion
Mar 12, 2020
Castration-Resistant Prostate Cancer Trial (SHR3680 tablets)
Not yet recruiting
- Castration-Resistant Prostate Cancer
- SHR3680 tablets
- (no location specified)
Nov 1, 2022
HSV Infection Trial in London (Pritelivir and moxifloxacin , Pritelivir , moxifloxacin and moxifloxacin , Pritelivir ,
Recruiting
- HSV Infection
- Pritelivir and moxifloxacin placebo
- +2 more
-
London, United KingdomRichmond Pharmacology Ltd
Jan 3, 2023
Healthy Subject Trial in Beijing (Orelabrutinib and (orelabrutinib tablet simulator), Orelabrutinib, Placebo (orelabrutinib
Active, not recruiting
- Healthy Subject
- Orelabrutinib and placebo (orelabrutinib tablet simulator)
- +3 more
-
Beijing, ChinaBeijing GoBroad Boren Hospital
Dec 19, 2022
Long QT Syndrome Trial in West Bend (LQT-1213, Placebo, Dofetilide 250 µg Cap)
Active, not recruiting
- Long QT Syndrome
- LQT-1213
- +2 more
-
West Bend, WisconsinSpaulding Clinical Research, LLC
Jun 15, 2023
Healthy Volunteers Trial in Antwerpen (P03277 0.1 mmol/kg, Moxifloxacin 400mg, NaCl 0.9%)
Completed
- Healthy Volunteers
- P03277 0.1 mmol/kg
- +3 more
-
Antwerpen, BelgiumClinical Pharmacology unit, SGS-Life Science Service
Mar 22, 2022
Healthy Trial in Glendale (Setmelanotide, Moxifloxacin, Oral Placebo)
Completed
- Healthy
- Setmelanotide
- +3 more
-
Glendale, CaliforniaParexel Early Phase Clinical Unit (Los Angeles)
Jun 15, 2022
Phenylketonuria Trial in Fargo (sapropterin diHCl, Moxifloxacin, Moxifloxacin )
Completed
- Phenylketonuria
- sapropterin dihydrochloride
- +2 more
-
Fargo, North DakotaPRACS Institute, Ltd.
Jul 19, 2021
Castration-Resistant Prostate Cancer Trial in Worldwide (Apalutamide)
Active, not recruiting
- Castration-Resistant Prostate Cancer
-
Greenville, South Carolina
- +4 more
Aug 2, 2022
Detected From LINQ ECG During and After Antiarrhythmic Loading
Not yet recruiting
- Atrial Arrhythmia
- +2 more
- LINQ/LINQ II
- (no location specified)
Aug 11, 2022